Piramal Pharma Delivers a Dose of Growth: Q4 Profits Surge, Revenue Climbs

Unknown Apr 02, 2026 400 Views

Piramal Pharma Limited disclosed its quarter-end March 2025 financial performance, which remained strong with a high revenue and profitability growth. The company saw a consolidated revenue from operations at ₹2,754 crore (₹27.54 billion), which rose by 8% from the corresponding quarter last year...